Swarajya
Our View
Magazine
Dashboards
Subscribe
Swarajya
Subscribe
Get App
Home
Dashboards
Magazine
Swarajya
Politics
Economics
Business
Culture
Infra
Defence
World
Books
Ideas
Science
Technology
Heritage
Archives
Subscriber login
Politics
Economics
Business
Culture
Infra
Defence
World
Books
Ideas
Science
Technology
Heritage
Archives
Novavax
Serum Institute of India Seeks DCGI Nod For COVID-19 Vaccine COVOVAX
PTI
Saturday, October 30, 2021 10:03 AM IST
Serum Institute Receives Approval To Launch Covovax Trials On Children Aged 7-11
Bhaswati Guha Majumder
Wednesday, September 29, 2021 04:37 PM IST
US Pharma Major J&J Seeks Emergency Use Approval For Its Single-Shot COVID-19 Vaccine In India
Swarajya Staff
Friday, August 6, 2021 04:14 PM IST
Novavax Is Facing Funding Issues In The US But Seeking Emergency Approval In Needy Countries
Bhaswati Guha Majumder
Friday, August 6, 2021 02:08 PM IST
Novavax Seeks DCGI's Approval For Emergency Use Of Its Covid-19 Vaccine In India
Swarajya Staff
Friday, August 6, 2021 09:29 AM IST
Serum Institute Begins Advance Production Of Its Upcoming Second Covid-19 Vaccine Novavax
Swarajya Staff
Saturday, June 26, 2021 09:29 AM IST
All You Need To Know About Four Covid-19 Vaccine Candidates In India For Children
Bhaswati Guha Majumder
Friday, June 18, 2021 04:49 PM IST
Serum Institute Likely To Begin Clinical Trial Of Covovax On Children In India From Next Month: Report
Swarajya Staff
Friday, June 18, 2021 04:18 PM IST
Amid Looming Uncertainty Over EUA In US, Novavax Eyes India Launch Of Its COVID Jab With Over 90 Per Cent Efficacy
Swarajya Staff
Tuesday, June 15, 2021 03:06 PM IST
Novavax Covid-19 Vaccine Is About 90 Per Cent Effective, Finds Large Study
Bhaswati Guha Majumder
Monday, June 14, 2021 05:40 PM IST
We Are Out Of Vaccine Panic Mode; Pfizer, Moderna Can’t Dictate Terms Any More
R Jagannathan
Wednesday, June 9, 2021 10:58 AM IST
From Novavax To Sanofi, Pharmaceutical Companies Develop A New Type Of Covid-19 Vaccine
Bhaswati Guha Majumder
Monday, June 7, 2021 08:02 PM IST
In A Setback To Global Vaccine Drive, Novavax Reports Further Delays In Approval And Production Of Covid-19 Vaccine
Swarajya Staff
Wednesday, May 12, 2021 09:58 AM IST
US-Based Novavax Begins Clinical Trials Of Its COVID-19 Vaccine Candidate On Adolescents Aged Between 12 To 17 Years
Swarajya Staff
Tuesday, May 4, 2021 09:55 AM IST
How Bharat Biotech Plans To Overcome Production Challenges Due To Export Restrictions On Raw Materials By US
Bhaswati Guha Majumder
Thursday, April 15, 2021 02:27 PM IST
Serum Institute Begins Phase Two And Three Bridging Trials Of Covid-19 Vaccine Candidate Covovax In India
Swarajya Staff
Saturday, March 27, 2021 11:36 AM IST
Novavax, J&J Covid-19 Vaccines Show Encouraging Results In Phase 3 Trials
Swarajya Staff
Saturday, January 30, 2021 02:34 PM IST
‘Made In India’ Covaxin’s Phase-1 Trial Results Are Out And They Are Promising
Swarajya Staff
Friday, December 18, 2020 05:24 PM IST
ICMR, Serum Institute Complete Enrolment In Phase 3 Clinical Trials For Covid-19 Vaccine 'Covishield'
Swarajya Staff
Thursday, November 12, 2020 11:32 AM IST
Government Secures Vaccine Supplies For Half Of The Indian Population From Serum Institute And Novavax: Report
Swarajya Staff
Tuesday, November 3, 2020 09:13 AM IST
Load More